VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 118 filers reported holding VIKING THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.31 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $35,002,222 | +251.0% | 3,161,899 | +413.9% | 0.07% | +222.7% |
| Q2 2023 | $9,973,494 | +7.6% | 615,268 | +10.5% | 0.02% | -4.3% |
| Q1 2023 | $9,267,507 | +850.1% | 556,607 | +436.4% | 0.02% | +666.7% |
| Q4 2022 | $975,438 | -86.6% | 103,770 | -96.1% | 0.00% | -86.4% |
| Q3 2022 | $7,272,000 | -4.8% | 2,673,564 | +1.2% | 0.02% | -12.0% |
| Q2 2022 | $7,638,000 | +10084.0% | 2,642,951 | +25288.6% | 0.02% | +2400.0% |
| Q2 2020 | $75,000 | +7.1% | 10,410 | +1.6% | 0.00% | – |
| Q3 2019 | $70,000 | -54.2% | 10,245 | -44.6% | 0.00% | -100.0% |
| Q2 2019 | $153,000 | -75.0% | 18,478 | -70.0% | 0.00% | -75.0% |
| Q1 2019 | $613,000 | -78.0% | 61,658 | -83.0% | 0.00% | -80.0% |
| Q4 2018 | $2,782,000 | -85.4% | 363,606 | -66.8% | 0.02% | -77.0% |
| Q3 2018 | $19,072,000 | +688.1% | 1,094,851 | +329.4% | 0.09% | +690.9% |
| Q2 2018 | $2,420,000 | – | 255,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| APIS CAPITAL ADVISORS, LLC | 148,000 | $1,638,360 | 2.12% |
| Sio Capital Management, LLC | 595,002 | $6,586,672 | 2.04% |
| 5AM Venture Management, LLC | 585,000 | $6,475,950 | 1.86% |
| Artia Global Partners LP | 383,580 | $4,246,231 | 1.76% |
| Integral Health Asset Management, LLC | 800,000 | $8,856,000 | 1.23% |
| Boxer Capital, LLC | 2,000,000 | $22,140,000 | 1.18% |
| DAFNA Capital Management LLC | 319,655 | $3,538,581 | 1.10% |
| Affinity Asset Advisors, LLC | 332,600 | $3,681,882 | 1.04% |
| MPM BioImpact LLC | 325,000 | $3,597,750 | 0.96% |
| Affinity Asset Advisors, LLC | 300,000 | $3,321,000 | 0.93% |